Back to Search
MATTHEW YOUNG, MD
MD
Ophthalmology Physician
NPI: 1609212844IndividualAccepts Medicare
Specialties, Licenses & Credentials
Glaucoma Specialist (Ophthalmology) Physician
Ophthalmology — Glaucoma Specialist
Code: 207WX0009X
0101264079(VA)
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
77997(GA)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
VIRGINIA COMMONWEALTH UNIVERSITY, SCHOOL OF MEDICINE
Class of 2013
Research & Publications (20)
Matisse to Picasso: a compositional study of modern bronze sculptures.
PMID 19629458·Anal Bioanal Chem·2009
8-other
Risk assessment of isolated aripiprazole exposures and toxicities: a retrospective study.
PMID 19586356·Clin Toxicol (Phila)·2009
8-other
Management of food allergies in schools: a perspective for allergists.
PMID 19493563·J Allergy Clin Immunol·2009
6-review
Autocrine motility-stimulatory pathways of oral premalignant lesion cells.
PMID 17370039·Clin Exp Metastasis·2007
8-other
Oral premalignant lesions induce immune reactivity to both premalignant oral lesions and head and neck squamous cell carcinoma.
PMID 17096152·Cancer Immunol Immunother·2007
8-other
Tumor skewing of CD34+ cell differentiation from a dendritic cell pathway into endothelial cells.
PMID 16025265·Cancer Immunol Immunother·2006
7-preclinical
Cytokine-containing gelfoam implants at a postsurgical tumor excision site to stimulate local immune reactivity.
PMID 16450395·Int J Cancer·2006
7-preclinical
Protective mechanisms of head and neck squamous cell carcinomas from immune assault.
PMID 16284974·Head Neck·2006
6-review
Combination docetaxel plus vitamin D(3) as an immune therapy in animals bearing squamous cell carcinomas.
PMID 16213938·Otolaryngol Head Neck Surg·2005
7-preclinical
Tissue bioengineering: potential applications to glaucoma.
PMID 16344446·Arch Ophthalmol·2005
6-review
Tumor skewing of CD34+ progenitor cell differentiation into endothelial cells.
PMID 14991572·Int J Cancer·2004
7-preclinical
Tumor-derived prostaglandin E2 and transforming growth factor-beta stimulate endothelial cell motility through inhibition of protein phosphatase-2A and involvement of PTEN and phosphatidylinositide 3-kinase.
PMID 15516833·Angiogenesis·2004
7-preclinical
Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck.
PMID 14634795·Cancer Immunol Immunother·2004
6-review
Protein phosphatase-2A restricts migration of Lewis lung carcinoma cells by modulating the phosphorylation of focal adhesion proteins.
PMID 12455051·Int J Cancer·2003
7-preclinical
Protein phosphatase-2A regulates endothelial cell motility and both the phosphorylation and the stability of focal adhesion complexes.
PMID 12115541·Int J Cancer·2002
7-preclinical
Adult hepatitis B vaccination using a novel triple antigen recombinant vaccine.
PMID 11481622·Hepatology·2001
3-trial
Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.
PMID 11424117·J Med Virol·2001
3-trial
Impact of aging on immune modulation by tumor.
PMID 11570585·Cancer Immunol Immunother·2001
7-preclinical
A multi-center controlled study of rapid hepatitis B vaccination using a novel triple antigen recombinant vaccine.
PMID 11348708·Vaccine·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3855 GASKINS RD
HENRICO, VA 23233 - Phone
- (804) 217-6363
Quick Facts
- NPI
- 1609212844
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile